Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Acta Clin Belg ; 68(3): 223-4, 2013.
Article in English | MEDLINE | ID: mdl-24156226

ABSTRACT

We report here the case of a 51-year-old man presenting to the Emergency Department with a febrile cutaneous eruption with diffuse arthralgia 10 days after the onset of azathioprine therapy. The clinical examination did not reveal any inflammatory syndrome and the results of all bacteriological tests were negative. A skin biopsy was performed, which revealed a granulocytary pustula with superficial dermal oedema and a neutrophil infiltration without sign of vasculitis. A side effect of azathioprine was suspected, and treatment was discontinued. Fortunately, the patient recovered within a few days. Azathioprine hypersensitivity syndrome is a rare side effect of azathioprine. Hypersensitivity syndrome is an idiosyncratic, non-IgE-mediated reaction that appears to be unrelated to thiopurine methyltransferase levels. Diagnosis is mainly clinical and requires an exclusion of other processes. The only treatment option available is to stop azathioprine intake.


Subject(s)
Azathioprine/immunology , Crohn Disease/drug therapy , Immunosuppressive Agents/immunology , Sweet Syndrome/etiology , Sweet Syndrome/immunology , Biopsy , Humans , Male , Middle Aged
3.
Acta Clin Belg ; 64(4): 361-5, 2009.
Article in English | MEDLINE | ID: mdl-19810427

ABSTRACT

An abscess in the psoas muscle is rare and frequently misdiagnosed. A delay in the diagnosis can increase its mortality rate. Some clinical signs can help the clinician but they all are not always present, and not at the same time. We describe in this paper a case report of an association between a psoas abscess and a homolateral hip joint prosthesis infection. It was suspected because of no improvement in clinical state despite treatment of the abscess by antibiotics and drainage, and it required finally other complementary therapeutic solutions. The pathogenic microorganism was a group C streptococcus. We discuss all these points and thereafter we suggest some recommendations for the clinician.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Prosthesis-Related Infections/complications , Psoas Abscess/complications , Streptococcal Infections/complications , Streptococcus/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Follow-Up Studies , Humans , Male , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/drug therapy , Psoas Abscess/diagnosis , Psoas Abscess/microbiology , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Tomography, X-Ray Computed
4.
Rev Med Brux ; 29(1 Suppl): S19-24, 2008.
Article in French | MEDLINE | ID: mdl-18497216

ABSTRACT

The World Kidney Day offers a crucial opportunity to the Belgian associations of nephrologists to inform public and medical communities about the global problem of chronic kidney disease (CKD). According to epidemiological data from GNFB/ NBVN registries in our country, cardiovascular diseases and diabetes 2 are responsible for an increasing amount of CKD cases with pejorative evolution to end-stage renal disease requiring cost-effective renal replacement therapies (haemodialysis, peritoneal dialysis or renal transplantation). In these patients, the high level of comorbidities and the late referral to the nephrologists are recognized as enhanced morbidity and mortality factors. These facts underline the need for the nephrologists to stimulate collaboration with general practitioners and specialists from other disciplines in order to set up systematic screening procedures and early follow-up of patients at risk of developing CKD. These procedures should contribute to reduce the progression rate of renal function impairment.


Subject(s)
Kidney Diseases/epidemiology , Belgium/epidemiology , Family Practice , Global Health , Humans , Incidence , Kidney Failure, Chronic/epidemiology , Kidney Failure, Chronic/therapy , Nephrology , Registries , Societies, Medical
6.
J Pharm Belg ; 60(2): 41-50, 2005.
Article in French | MEDLINE | ID: mdl-16035368

ABSTRACT

These recommendations are largely based on the Executive Summary of the "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice" proposed by the "Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice". The model used to assess the overall risk was adapted for Belgium. Otherwise, very few things were changed from the Executive Summary of the European Guidelines.


Subject(s)
Cardiovascular Diseases/prevention & control , Belgium/epidemiology , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Female , Humans , Life Style , Male , Risk Management
7.
Rev Med Brux ; 26(2): 77-87, 2005.
Article in French | MEDLINE | ID: mdl-15945419

ABSTRACT

These recommendations are largely based on the Executive Summary of the "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice" proposed by the "Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice". The model used to assess the overall risk was adapted for Belgium. Otherwise, very few things were changed from the Executive Summary of the European Guidelines.


Subject(s)
Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/etiology , Decision Trees , Humans , Risk Factors
8.
Rev Med Liege ; 60(3): 163-72, 2005 Mar.
Article in French | MEDLINE | ID: mdl-15884699

ABSTRACT

These recommandations are largely based on the "European Guidelines on Cardiovascular Disease Prevention in Clinical Practice" proposed by the "Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice". The model used to assess the overall risk was adapted for Belgium. Otherwise, very few things were changed from the Exectutive Summary of the European Guidelines.


Subject(s)
Cardiovascular Diseases/prevention & control , Primary Health Care , Belgium , Humans , Risk Factors
10.
Clin Nephrol ; 62(2): 155-7, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15356974

ABSTRACT

Primary hyperoxaluria type 1 (PH1) is a rare autosomal metabolic recessive disease, caused by the deficiency of the liver peroxysomal alanine:glyoxylate aminotransferase (AGT), characterized by accumulation of calcium oxalate crystals in kidneys and others organs. We present the case of an elderly woman with PH1, presenting as acute renal failure. Precipitation of calcium oxalate crystals was probably due to amiodarone-induced severe hypothyroidism. Residual AGT activity is associated with the G170R (G630A) mutation. A new mutation of AGT, called R36C, was also discovered; the role of this new mutation is actually not known.


Subject(s)
Hyperoxaluria, Primary/etiology , Hypothyroidism/complications , Mutation , Renal Insufficiency/etiology , Age Factors , Aged , Disease Progression , Female , Humans , Hyperoxaluria, Primary/genetics , Time Factors
11.
Clin Nephrol ; 59(2): 98-105, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12608552

ABSTRACT

The occurrence of a post-renal transplant syndrome of lower limbs joint pain has been reported extensively over the last decade. Clinical examination of the symptomatic joints is often unremarkable and magnetic resonance imaging reveals abnormalities of the bone marrow suggestive of edema and/or hemorrhage. The main striking features of this syndrome are the spontaneous resolution of the symptoms within a few weeks as well as of the marrow abnormalities. This syndrome has been attributed to cyclosporine, given in the immunosuppression regimen or to epiphyseal impactions. We here document the occurrence of this syndrome in 5 kidney graft recipients given a tacrolimus-based immunosuppression.


Subject(s)
Immunosuppressive Agents/adverse effects , Kidney Transplantation , Pain/etiology , Tacrolimus/adverse effects , Adult , Female , Graft Rejection/prevention & control , Humans , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/surgery , Knee Joint/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Syndrome , Tacrolimus/therapeutic use
12.
Eur J Emerg Med ; 8(1): 17-20, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11314815

ABSTRACT

We present a retrospective review of Hantavirus infection in the emergency department. Thirteen cases of Hantavirus infections with renal syndrome from July 1989 to August 1999 were analysed. The diagnosis was confirmed by detection of Hantavirus antibodies in all cases. Fever, chills and headaches were universally present. Intense back pain was associated in 77% of the patients. Thrombocytopenia, abnormal urinalysis, hypertransaminasaemia, increased lactate dehydrogenase were the principal biological patterns. All these parameters returned to their normal level, and all the patients recovered a normal renal function without sequels. The management is supportive. Only one patient in our series had to be dialysed. Hantavirus disease should be included in the differential diagnosis of acute renal failure with thrombocytopenia, particularly in patients with suspected exposure in known endemic areas. The differential diagnosis of any perplexing case of undifferentiated febrile illness with acute renal failure and thrombocytopenia should include Hantavirus infection.


Subject(s)
Emergency Service, Hospital , Hantavirus Infections/diagnosis , Acute Kidney Injury/etiology , Adult , Aged , Belgium , Biomarkers/blood , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Retrospective Studies , Thrombocytopenia/etiology
14.
Acta Clin Belg ; 56(6): 360-3, 2001.
Article in English | MEDLINE | ID: mdl-11881321

ABSTRACT

Hyperoxaluria is rarely considered as a cause of rapidly progressive renal failure. A case is reported of a patient in whom rapidly renal failure developed after subtotal small bowel resection. A diagnosis of calcium oxalate deposits nephropathy was confirmed by renal biopsy. This cause of renal failure may be underestimated and should be systematically searched for in all patients with malabsorption.


Subject(s)
Hyperoxaluria/complications , Hyperoxaluria/diagnosis , Nephritis, Interstitial/complications , Nephritis, Interstitial/diagnosis , Renal Insufficiency/etiology , Aged , Disease Progression , Follow-Up Studies , Humans , Hyperoxaluria/therapy , Kidney Function Tests , Male , Nephritis, Interstitial/therapy , Renal Dialysis , Renal Insufficiency/pathology , Renal Insufficiency/therapy , Risk Assessment , Urinalysis
16.
Rev Rhum Engl Ed ; 66(1): 53-7, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10036701

ABSTRACT

Tumor-induced osteomalacia is due to renal phosphate wasting in response to a humoral factor produced by a tumor, usually a benign mesenchymal tumor. Removal of the tumor is followed by resolution of the metabolic disorder. Physicians should be aware that sporadic renal phosphate wasting in an adult should prompt a search for a tumor. A case of tumor-induced osteomalacia due to a nonossifying fibroma of the radius is reported. After removal of the tumor, renal phosphate excretion returned to normal, but the patient developed tertiary hyperparathyroidism. Eight years elapsed between symptom onset and the diagnosis of the tumor. The pathogenesis of tumor-induced osteomalacia and the role of treatment for renal phosphate wasting on the subsequent development of hyperthyroidism are discussed.


Subject(s)
Bone Neoplasms/complications , Fibroma/complications , Hyperparathyroidism/complications , Osteomalacia/etiology , Adenoma/blood , Adenoma/complications , Alkaline Phosphatase/blood , Bone Neoplasms/blood , Bone Neoplasms/diagnostic imaging , Calcium/blood , Female , Fibroma/blood , Fibroma/diagnostic imaging , Humans , Hyperparathyroidism/blood , Hyperparathyroidism/etiology , Kidney Diseases/blood , Kidney Diseases/complications , Middle Aged , Neoplasms, Second Primary/blood , Neoplasms, Second Primary/complications , Osteomalacia/blood , Osteomalacia/diagnostic imaging , Parathyroid Neoplasms/blood , Parathyroid Neoplasms/complications , Phosphates/blood , Radiography
18.
Pathol Biol (Paris) ; 46(1): 8-14, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9769930

ABSTRACT

We have shown that administration of inorganic potassium phosphates (Pi) to patients with severe diabetic ketoacidosis was able to increase the P50 (the PO2 necessary to achieve a hemoglobin saturation of 50%) by a non diphosphoglycerate (DPG) mediated effect. This suggests that the oxyhemoglobin dissociation curve (ODC) may be determined not only by pH, temperature, CO2 content and DPG but also by plasmatic ions. In order to test this hypothesis we have determined the ODC on whole blood in two groups of subjects, 49 control subjects with matching age and sex and 49 patients suffering from liver cirrhosis, acute pancreatitis, septic shock and acute respiratory distress syndrome. The patients had many ionic disorders induced either by their diseases or by the applied treatment. The mean ODC of the patients did not differ from the normal values. In contrast, the dispersion of PO2 around the saturations values was increased from 5 to 80% saturation. A forward regression analysis showed that the DPG level and the levels of inorganic phosphates and natrium (Na+) played a significant role in determining the position of the ODC according to the following equation: P50 (mmHg) = 34.5 + 0.225 DPG + 0.62 Pi-0.09 Na+, where DPG is in micromol.gHb-1 and Pi and Na+ in mEq.l-1. In separate experiments we showed that the Bohr effect as expressed in d (log PO2)/dpH amounted to -0.53, -0.46 and -0.42 for SO2 equal to 5%, 50% and 95%, respectively. The corresponding values for the temperature effect was expressed in d (log PO2)/dT amounted to 0.028, 0.024, and 0.020 respectively. The fact that ions play an role in regulating the position of the ODC of patients with ionic disorders may have therapeutical implications, preventive or curative.


Subject(s)
Critical Care , Oxyhemoglobins/drug effects , Phosphates/pharmacology , Potassium Compounds/pharmacology , Adult , Aged , Case-Control Studies , Female , Humans , Ions , Liver Cirrhosis/blood , Male , Middle Aged , Oxyhemoglobins/chemistry , Respiratory Distress Syndrome/blood , Shock, Septic/blood
19.
Clin Exp Dermatol ; 23(6): 274-6, 1998 Nov.
Article in English | MEDLINE | ID: mdl-10233625

ABSTRACT

Acitretin (Ro 10-1670 or Neotigason), a free acid and the main metabolite of etretinate (Ro 10-9359 or Tigason), is the most recent of the retinoids used orally in the treatment of psoriasis and numerous other dermatoses exhibiting disorders of keratinization. In the majority of cases, its side-effects are similar to those of hypervitaminosis A.


Subject(s)
Acitretin/adverse effects , Gout/chemically induced , Keratolytic Agents/adverse effects , Aged , Aged, 80 and over , Calcium/urine , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...